FindTrial
Sign In

Active Comparator Biological/Vaccine,Experimental Biological/Vaccine,Active Comparator Biological/Vaccine

2 trials

Sponsors

National Vaccine Institute, Siriraj Grant for Research Development

Conditions

Healthy Thai children aged 5-17 years who received two doses of the mRNA vaccine (BNT162b2). children, Booster dose, Third vaccination, SARS-CoV-2, COVID-19, vaccines, mRNA vaccines, Adverse events, Vaccine safetyPrevention of COVID-19 with SARS-CoV-2 mRNA vaccine platform, comparing standard and prolong interval, in healthy Thai children SARS-CoV-2, mRNA vaccine, COVID-19 vaccine, Children, Immunogenicity, Reactogenicity

Phase 2

Safety and Immunogenicity of SARS-CoV-2 mRNA vaccine platform in Thai children aged 5-11 years
Active, not recruitingTCTR20220125002
National Vaccine InstitutePrevention of COVID-19 with SARS-CoV-2 mRNA vaccine platform, comparing standard and prolong interval, in healthy Thai children SARS-CoV-2, mRNA vaccine, COVID-19 vaccine, Children, Immunogenicity, Reactogenicity
Start: 2022-02-19Target: 400Updated: 2026-08-03

Phase 4

SARS-CoV-2 antibody response after a booster dose of the mRNA COVID-19 vaccine (BNT162b2) among Thai children and adolescents aged 5-17 years.
Active, not recruitingTCTR20230424002
Siriraj Grant for Research DevelopmentHealthy Thai children aged 5-17 years who received two doses of the mRNA vaccine (BNT162b2). children, Booster dose, Third vaccination, SARS-CoV-2, COVID-19, vaccines, mRNA vaccines, Adverse events, Vaccine safety
Start: 2022-05-28Target: 150Updated: 2026-08-03